News & Events
Cancer
Nobel Prize recognises growing relevance of immunotherapy in...
The decision to award a Nobel Prize to two leading immunotherapy researchers is well ...
Scope 66 - David Downs: CAR T-cell recipient
David Downs, cancer survivor and self-declared ‘genetically modified organism’ recent...
Health Research Council backs Malaghan Institute to continue...
The Malaghan Institute of Medical Research’s outstanding programmes of scientific dis...
Scope 65 - Global effort in the fight against cancer
Breakthroughs don’t happen in isolation. Typically, they are the steady accumulat...
Scope 64 - Ankle-tapping cancer: reducing therapy resistance...
Cancer is particularly good at shrugging off whatever is thrown at it, ploughing ...
Scope 64 - Research in focus: Cancer immunotherapy
The Cancer Immunotherapy programme has successfully completed the latest round of ...
Scope 64 - Our people: Dr Laura Ferrer-Font
As the potential of immunotherapy grows, so must our team of specialised staff an...
Official opening of Wellington Zhaotai Therapies, Malaghan I...
Earlier this month, the Malaghan Institute was excited to welcome a mayoral delegatio...
Scope 63 - Informing Immunotherapy - profiling Innate T cell...
In the quest for treating a disease as diverse as cancer, multiple approaches are exp...
Scope 63 - Research From Bench to Bedside
Every scientific researcher’s ultimate aim is to discover and develop new treatments ...